Published: June 5, 2026 โข 12:04 AM IST ยท Updated: June 5, 2026 โข 8:36 AM ISTBy TheBriefWire Editorial Team
Key points
In particular, Zoetis saw volumes surge.
The company last year received conditional approval from the U.S. Food and Drug Administration for an injectable product that treats and prevents reinfestation of the pest.
Last month, the FDA extended its support by issuing emergency use authorization for the over-the-counter drug.
Options volume in Zoetis jumped to almost 20 times the daily average, with just under 12,000 contracts traded and almost 11,000 in calls.
More than 4,200 calls were bought, compared with 1,200 calls sold and under 300 puts bought.